Showing 4,861 - 4,880 results of 18,470 for search 'significantly ((((lower decrease) OR (((nn decrease) OR (a decrease))))) OR (linear decrease))', query time: 0.69s Refine Results
  1. 4861
  2. 4862
  3. 4863

    Probability of Cost-Effectiveness Across CET. by Yiping An (20609789)

    Published 2025
    “…When the CET was relaxed to 0.90 times GDP per capita (US$11,284.476), the probability of cost-effectiveness for AOM after a 40% price reduction rose to 85.10%. Scenario analyses conducted over a time horizon extending from 10 to 30 years showed that the ICER decreased significantly with longer follow-up, gradually approaching the 0.51GDP threshold and remaining below the 0.90 GDP threshold throughout the analysis.…”
  4. 4864

    Base-case analysis. by Yiping An (20609789)

    Published 2025
    “…When the CET was relaxed to 0.90 times GDP per capita (US$11,284.476), the probability of cost-effectiveness for AOM after a 40% price reduction rose to 85.10%. Scenario analyses conducted over a time horizon extending from 10 to 30 years showed that the ICER decreased significantly with longer follow-up, gradually approaching the 0.51GDP threshold and remaining below the 0.90 GDP threshold throughout the analysis.…”
  5. 4865
  6. 4866
  7. 4867

    The original plotting data. by Hongmei Qian (538647)

    Published 2024
    “…<div><p>Background</p><p>Glaucoma, characterized by a high incidence and significant ocular harm, has been elucidated through various mechanisms. …”
  8. 4868

    Background characteristics of study participants. by Awole Seid (3839965)

    Published 2025
    “…</p><p>Conclusion</p><p>Symptoms vary in onset, severity, and pattern among individuals, significantly impacting their quality of life. Nutritional support is a pressing need for cancer patients. …”
  9. 4869

    Dataset. by Awole Seid (3839965)

    Published 2025
    “…</p><p>Conclusion</p><p>Symptoms vary in onset, severity, and pattern among individuals, significantly impacting their quality of life. Nutritional support is a pressing need for cancer patients. …”
  10. 4870
  11. 4871
  12. 4872

    Summary of codes generated from MAXQDA software. by Awole Seid (3839965)

    Published 2025
    “…</p><p>Conclusion</p><p>Symptoms vary in onset, severity, and pattern among individuals, significantly impacting their quality of life. Nutritional support is a pressing need for cancer patients. …”
  13. 4873

    Fabrication of Ionic Supramolecular Oleogel Lubricants Enhanced with Liquid Metal Nanodroplets for Superior Tribological Performance by Tiantian Wang (1688881)

    Published 2024
    “…Compared to the base oil PAO10, the coefficient of friction (COF) for both GLM@IGel-1 and GLM@IGel-2 decreased significantly from 0.192 to 0.097, while the wear volume dropped from 100.10 × 10<sup>4</sup> μm<sup>3</sup> to 13.28 × 10<sup>4</sup> μm<sup>3</sup> for GLM@IGel-1, and to 9.69 × 10<sup>4</sup> μm<sup>3</sup> for GLM@IGel-2. …”
  14. 4874

    Schematic presentation of themes and categories. by Awole Seid (3839965)

    Published 2025
    “…</p><p>Conclusion</p><p>Symptoms vary in onset, severity, and pattern among individuals, significantly impacting their quality of life. Nutritional support is a pressing need for cancer patients. …”
  15. 4875
  16. 4876

    The raw data for Fig 4. by Hongjoo An (21703199)

    Published 2025
    “…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”
  17. 4877

    The raw data for S2 Fig. by Hongjoo An (21703199)

    Published 2025
    “…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”
  18. 4878
  19. 4879

    The raw data for Fig 6. by Hongjoo An (21703199)

    Published 2025
    “…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”
  20. 4880

    The raw data for S4 Fig. by Hongjoo An (21703199)

    Published 2025
    “…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”